The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis
2017; Springer Nature; Volume: 32; Issue: 2 Linguagem: Inglês
10.1038/leu.2017.216
ISSN1476-5551
AutoresP Garrido Castro, Eddy H.J. Van Roon, Sandra S. Pinhanços, Luca Trentin, Pauline Schneider, Mark Kerstjens, Geertruy te Kronnie, Olaf Heidenreich, Rob Pieters, Ronald W. Stam,
Tópico(s)Epigenetics and DNA Methylation
Referência(s)